Sandu Pharmaceuticals Ltd — Important, 14-08-2026: Company Update

Sandu Pharmaceuticals has scheduled its 41st Annual General Meeting for September 11, 2026, at 4:30 PM IST, to be held via video conference. The Board earlier **put forward** a dividend of Re 1.00 per equity share for the financial year ending March 31, 2026. This dividend requires shareholder approval at the AGM. Shareholders should ensure their email and bank details are updated with the company or their depository participant for timely receipt of the annual report, dividend, and other updates. Tax deduction at source (TDS) will apply to dividends, and relevant documents must be submitted by September 4, 2026.